Correlation of histological grade and expression of adhesion molecules in canine mammary gland carcinomas

Marie Golis, Jana Lorenzová, Lucie Urbanová, Aneta Angelová, Barbora Moldovan Putnová, Zita Filipejová, Michal Crha, Alois Nečas

Correlation of histological grade and expression of adhesion molecules in canine mammary gland carcinomas

Číslo: 1/2024
Periodikum: Acta Veterinaria Brno
DOI: 10.2754/avb202493010011

Klíčová slova: β-catenin, E-cadherin, carcinoma, expression index.

Pro získání musíte mít účet v Citace PRO.

Přečíst po přihlášení

Anotace: The histological grade is usually used as a prognostic factor in canine mammary gland carcinomas, but the actual biological behaviour is not always in accordance with this available tool. Disrupted expression of cell adhesion molecules is a very promising way how to predict possible tumour spread. The goal of this study was to detect and quantify the expression of adhesion molecule E-cadherin and β-catenin by means of immunofluorescence and relate the findings with the histological grade in 18 samples of canine mammary gland carcinomas. There is a disruption of β-catenin and E-cadherin expression in canine mammary carcinoma. Significantly positive correlation was found between the expression index of E-cadherin and β-catenin with the histological grade. A significant difference (P < 0.05) in the membrane index (MI) of β-catenin expression was found between groups of canine mammary carcinomas (CMCs) grade I and II, grade I and III, grade II and III. A significant difference (P < 0.05) in the MI of E-cadherin expression was also found between groups of CMCs grade I and II, grade I and III, grade II and III. A significant difference (P < 0.05) in the cytoplasmic index (CI) of β-catenin expression was found between groups of CMCs grade I and II, grade I and III. In the case of CI expression of E-cadherin, no significant difference was found in the expression of E-cadherinin CMCs of different grade. The results of the study show that these adhesion molecules could be promising markers in determining the prognosis of patients with CMCs.